Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other Non-Current Liabilities (2023 - 2025)

Historic Other Non-Current Liabilities for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $76000.0.

  • Profound Medical's Other Non-Current Liabilities rose 270.27% to $76000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $76000.0, marking a year-over-year increase of 270.27%. This contributed to the annual value of $71000.0 for FY2024, which is 273.97% down from last year.
  • Per Profound Medical's latest filing, its Other Non-Current Liabilities stood at $76000.0 for Q3 2025, which was up 270.27% from $77000.0 recorded in Q2 2025.
  • Over the past 5 years, Profound Medical's Other Non-Current Liabilities peaked at $77000.0 during Q2 2025, and registered a low of $71000.0 during Q4 2024.
  • Its 3-year average for Other Non-Current Liabilities is $73375.0, with a median of $72500.0 in 2023.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 273.97% in 2024, then skyrocketed by 694.44% in 2025.
  • Profound Medical's Other Non-Current Liabilities (Quarter) stood at $73000.0 in 2023, then decreased by 2.74% to $71000.0 in 2024, then grew by 7.04% to $76000.0 in 2025.
  • Its last three reported values are $76000.0 in Q3 2025, $77000.0 for Q2 2025, and $72000.0 during Q1 2025.